 | Up a level |
Milani, Mateus, Beckett, Alison J 
ORCID: 0000-0001-8377-325X, Al-Zebeeby, Aoula, Luo, Xu, Prior, Ian A ORCID: 0000-0002-4055-5161, Cohen, Gerald M and Varadarajan, Shankar ORCID: 0000-0002-8827-6567
(2019)
DRP-1 functions independently of mitochondrial structural perturbations to facilitate BH3 mimetic-mediated apoptosis.
Cell death discovery, 5.
117 - 117.
Carter, Rachel J, Milani, Mateus, Butterworth, Michael, Alotibi, Ahoud, Harper, Nicholas, Yedida, Govindaraju, Greaves, Georgia, Al-Zebeeby, Aoula, Jorgensen, Andrea L, Schache, Andrew G ORCID: 0000-0001-9466-6038 et al (show 7 more authors)
(2019)
Exploring the potential of BH3 mimetic therapy in squamous cell carcinoma of the head and neck.
CELL DEATH & DISEASE, 10.
Henz, Kristina, Al-Zebeeby, Aoula, Basoglu, Marion, Fulda, Simone, Cohen, Gerald M, Varadarajan, Shankar ORCID: 0000-0002-8827-6567 and Vogler, Meike
(2019)
Selective BH3-mimetics targeting BCL-2, BCL-X-L or MCL-1 induce severe mitochondrial perturbations.
BIOLOGICAL CHEMISTRY, 400 (2).
181 - 185.
Al-Zebeeby, Aoula, Vogler, Meike, Milani, Mateus, Richards, Caitlin, Alotibi, Ahoud, Greaves, Georgia, Dyer, Martin JS, Cohen, Gerald M and Varadarajan, Shankar ORCID: 0000-0002-8827-6567
(2018)
Targeting intermediary metabolism enhances the efficacy of BH3 mimetic therapy in haematological malignancies.
Haematologica: the hematology journal.
Al-Zebeeby, Aoula, Vogler, Meike, Milani, Mateus, Richards, Caitlin, Alotibi, Ahoud, Greaves, Georgia, Dyer, Martin JS, Cohen, Gerald M and Varadarajan, Shankar ORCID: 0000-0002-8827-6567
(2018)
Targeting intermediary metabolism enhances the efficacy of BH3 mimetic therapy in haematological malignancies.
Haematologica: the hematology journal.